MedTrace Logo

An Outcome Analysis of Primary Membranous Nephropathy

NCT06242327 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2026-03-23

No results posted yet for this study

Summary

This is an observational study intended to track the course of the primary membranous nephropathy disease in real-world clinical practice.

The study will primarily assess the long-term outcomes of patients with primary membranous nephropathy in the context of advances in treatment options.

Conditions

Sponsors & Collaborators

  • Mario Negri Institute for Pharmacological Research

    lead OTHER

Principal Investigators

  • Giuseppe Remuzzi, MD · Istituto Di Ricerche Farmacologiche Mario Negri

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-29
Primary Completion
2029-06-30
Completion
2054-06-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06242327 on ClinicalTrials.gov